Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
Travel and Tropical Medicine
How do you approach management of patients who develop arthritis following asymptomatic or mild chikungunya infection?
Do you commonly see development of arthritis following asymptomatic or mild chikungunya infection?
Related Questions
Have you used Karius to aid in the diagnosis of a non-resolving pneumonia, with negative bronchoscopy, biopsy, and other infectious work up in an immunocompetent patient?
What is your approach to vaccinations and titers for patients with myeloma, who are immunosuppressed and do not have appropriate antibody responses to vaccines?
Do add a macrolide for immunomodulatory effect in patients with macrolide-resistant M. abscessus?
Do you routinely recommend IV systemic antibiotic therapy in additional to intravitreal antibiotic therapy for exogenous bacterial endophthalmitis?
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
Is there a role for empiric scabies treatment in itchy patients without clear clinical signs of scabies?
What is your approach to antiviral treatment of HSV acute retinal necrosis?
For which patients could you consider direct oral amoxicillin challenge as opposed to skin testing for penicillin allergy de-labeling?
Do you routinely treat patients with neurosyphilis with IM penicillin for 1-3 weeks after completing a full treatment course of IV penicillin?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?